These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 29072974)
1. The Occurrence of Antibodies Against Gluten in Children with Autism Spectrum Disorders Does Not Correlate with Serological Markers of Impaired Intestinal Permeability. Józefczuk J; Konopka E; Bierła JB; Trojanowska I; Sowińska A; Czarnecki R; Sobol L; Józefczuk P; Surdy W; Cukrowska B J Med Food; 2018 Feb; 21(2):181-187. PubMed ID: 29072974 [TBL] [Abstract][Full Text] [Related]
2. Serological tests in gluten sensitivity (nonceliac gluten intolerance). Volta U; Tovoli F; Cicola R; Parisi C; Fabbri A; Piscaglia M; Fiorini E; Caio G J Clin Gastroenterol; 2012 Sep; 46(8):680-5. PubMed ID: 22138844 [TBL] [Abstract][Full Text] [Related]
3. [Frequency of determining markers of casein's inhability and gluten in children with disorders of autistic spectrum]. Bavykina IA; Popov VI; Zvyagin AA; Bavykin DV Vopr Pitan; 2019; 88(4):41-47. PubMed ID: 31722140 [TBL] [Abstract][Full Text] [Related]
4. Markers of Celiac Disease and Gluten Sensitivity in Children with Autism. Lau NM; Green PH; Taylor AK; Hellberg D; Ajamian M; Tan CZ; Kosofsky BE; Higgins JJ; Rajadhyaksha AM; Alaedini A PLoS One; 2013; 8(6):e66155. PubMed ID: 23823064 [TBL] [Abstract][Full Text] [Related]
5. Antibodies against food antigens in patients with autistic spectrum disorders. de Magistris L; Picardi A; Siniscalco D; Riccio MP; Sapone A; Cariello R; Abbadessa S; Medici N; Lammers KM; Schiraldi C; Iardino P; Marotta R; Tolone C; Fasano A; Pascotto A; Bravaccio C Biomed Res Int; 2013; 2013():729349. PubMed ID: 23984403 [TBL] [Abstract][Full Text] [Related]
6. [Markers of gluten intolerance in children with autism spectrum disorders and Down'syndrome]. Bavykina IA; Zvyagin AA; Petrova IV; Nastausheva TL Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(5. Vyp. 2):64-68. PubMed ID: 30141790 [TBL] [Abstract][Full Text] [Related]
7. [Zonulin and I-FABP are markers of enterocyte damage in celiac disease]. Bykova SV; Sabelnikova EA; Novikov AA; Baulo EV; Khomeriki SG; Parfenov AI Ter Arkh; 2022 May; 94(4):511-516. PubMed ID: 36286801 [TBL] [Abstract][Full Text] [Related]
8. Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis. Tornai T; Palyu E; Vitalis Z; Tornai I; Tornai D; Antal-Szalmas P; Norman GL; Shums Z; Veres G; Dezsofi A; Par G; Par A; Orosz P; Szalay F; Lakatos PL; Papp M World J Gastroenterol; 2017 Aug; 23(29):5412-5421. PubMed ID: 28839442 [TBL] [Abstract][Full Text] [Related]
9. Increased prevalence of antibodies against dietary proteins in children and young adults with cerebral palsy. Stenberg R; Dahle C; Magnuson A; Hellberg D; Tysk C J Pediatr Gastroenterol Nutr; 2013 Feb; 56(2):233-8. PubMed ID: 22983381 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of anti-gliadin antibodies in Non Celiac Gluten Sensitivity (NCGS) patients: A dual statistical approach. Infantino M; Manfredi M; Meacci F; Grossi V; Severino M; Benucci M; Bellio E; Bellio V; Nucci A; Zolfanelli F; Ugolini S; Catani S; Macchia D Clin Chim Acta; 2015 Dec; 451(Pt B):135-41. PubMed ID: 26404177 [TBL] [Abstract][Full Text] [Related]
11. Anti-gliadin antibodies in non-celiac gluten sensitivity. Infantino M; Meacci F; Grossi V; Macchia D; Manfredi M Minerva Gastroenterol Dietol; 2017 Mar; 63(1):1-4. PubMed ID: 27845509 [TBL] [Abstract][Full Text] [Related]
12. Measures of gluten-related reactivity in children with autism spectrum disorders in the absence of overt gastrointestinal symptoms: a pilot study from the United Arab Emirates. Abdel-Maksoud M; Aly El-Gabry D; Al Kayoumi T; Alketbi J; Mohamednour D; Elhassan Elamin M; Subhash Reddy M; Al Yafei ZA; Stip E; Abdel Aziz K; Arnone D J Int Med Res; 2020 Sep; 48(9):300060520952655. PubMed ID: 32959707 [TBL] [Abstract][Full Text] [Related]
13. [Gliadomorphin, casomorphin, and intestinal fatty acid binding protein in children with autism spectrum disorders]. Bavykina IA; Popov VI; Zvyagin AA; Bavykin DV Vopr Pitan; 2021; 90(3):20-27. PubMed ID: 34264553 [TBL] [Abstract][Full Text] [Related]
14. Increased Serum Zonulin Levels as an Intestinal Permeability Marker in Autistic Subjects. Esnafoglu E; Cırrık S; Ayyıldız SN; Erdil A; Ertürk EY; Daglı A; Noyan T J Pediatr; 2017 Sep; 188():240-244. PubMed ID: 28502607 [TBL] [Abstract][Full Text] [Related]
15. Gliadin does not induce mucosal inflammation or basophil activation in patients with nonceliac gluten sensitivity. Bucci C; Zingone F; Russo I; Morra I; Tortora R; Pogna N; Scalia G; Iovino P; Ciacci C Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1294-1299.e1. PubMed ID: 23639603 [TBL] [Abstract][Full Text] [Related]
16. Zonulin-Dependent Intestinal Permeability in Children Diagnosed with Mental Disorders: A Systematic Review and Meta-Analysis. Asbjornsdottir B; Snorradottir H; Andresdottir E; Fasano A; Lauth B; Gudmundsson LS; Gottfredsson M; Halldorsson TI; Birgisdottir BE Nutrients; 2020 Jul; 12(7):. PubMed ID: 32635367 [TBL] [Abstract][Full Text] [Related]
17. Production of antibodies to gliadin by peripheral blood lymphocytes in children with celiac disease: the use of an enzyme-linked immunospot technique for screening and follow-up. Hansson T; Dannaeus A; Kraaz W; Sjöberg O; Klareskog L Pediatr Res; 1997 Apr; 41(4 Pt 1):554-9. PubMed ID: 9098859 [TBL] [Abstract][Full Text] [Related]
18. Effect of gliadin on permeability of intestinal biopsy explants from celiac disease patients and patients with non-celiac gluten sensitivity. Hollon J; Puppa EL; Greenwald B; Goldberg E; Guerrerio A; Fasano A Nutrients; 2015 Feb; 7(3):1565-76. PubMed ID: 25734566 [TBL] [Abstract][Full Text] [Related]
19. Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease. Agardh D Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1276-81. PubMed ID: 17683995 [TBL] [Abstract][Full Text] [Related]
20. Gluten and casein supplementation does not increase symptoms in children with autism spectrum disorder. Pusponegoro HD; Ismael S; Firmansyah A; Sastroasmoro S; Vandenplas Y Acta Paediatr; 2015 Nov; 104(11):e500-5. PubMed ID: 26148018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]